GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Market Cap

Aptamer Group (LSE:APTA) Market Cap : £3.74 Mil (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aptamer Group's share price for the quarter that ended in Dec. 2023 was £0.0115. Aptamer Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 467.34 Mil. Therefore, Aptamer Group's market cap for the quarter that ended in Dec. 2023 was £5.37 Mil.

Aptamer Group's quarterly market cap declined from Dec. 2022 (£35.21 Mil) to Jun. 2023 (£4.66 Mil) but then increased from Jun. 2023 (£4.66 Mil) to Dec. 2023 (£5.37 Mil).

Aptamer Group's annual market cap increased from Mar. 2020 (£0.00 Mil) to Jun. 2022 (£66.26 Mil) but then declined from Jun. 2022 (£66.26 Mil) to Jun. 2023 (£4.66 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aptamer Group's Enterprise Value for Today is £3.04 Mil.


Aptamer Group Market Cap Historical Data

The historical data trend for Aptamer Group's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Market Cap Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Market Cap
- - 66.26 4.66

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial 92.73 66.26 35.21 4.66 5.37

Competitive Comparison of Aptamer Group's Market Cap

For the Biotechnology subindustry, Aptamer Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptamer Group's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Market Cap distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Market Cap falls into.



Aptamer Group Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Aptamer Group's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=£0.0675*69.0917
=£4.66

Aptamer Group's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=£0.0115*467.344
=£5.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptamer Group  (LSE:APTA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Aptamer Group Market Cap Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines